Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
AT1 receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA AT1 Receptor Antagonists market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA AT1 Receptor Antagonists market. Detailed analysis of key players, along with key growth strategies adopted by AT1 Receptor Antagonists industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi SA
Astra Zeneca
GSK
Jhonson and Johnson
Bayer
Novartis
Teva Pharmaceutical
Eli Lilly and Company
Pfizer
Bristol-Myers Squibb
Merck
By Type:
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
By End-User:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of AT1 Receptor Antagonists Market
-
1.3 Market Segment by Type
-
1.3.1 USA AT1 Receptor Antagonists Market Size and Growth Rate of Valsartan from 2016 to 2027
-
1.3.2 USA AT1 Receptor Antagonists Market Size and Growth Rate of Telmisartan from 2016 to 2027
-
1.3.3 USA AT1 Receptor Antagonists Market Size and Growth Rate of Losartan from 2016 to 2027
-
1.3.4 USA AT1 Receptor Antagonists Market Size and Growth Rate of Irbesartan from 2016 to 2027
-
1.3.5 USA AT1 Receptor Antagonists Market Size and Growth Rate of Azilsartan from 2016 to 2027
-
1.3.6 USA AT1 Receptor Antagonists Market Size and Growth Rate of Olmesartan from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA AT1 Receptor Antagonists Market Size and Growth Rate of Hypertension from 2016 to 2027
-
1.4.2 USA AT1 Receptor Antagonists Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
1.4.3 USA AT1 Receptor Antagonists Market Size and Growth Rate of Kidney Diseases from 2016 to 2027
-
1.4.4 USA AT1 Receptor Antagonists Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of AT1 Receptor Antagonists Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of AT1 Receptor Antagonists by Major Types
-
3.4.1 Market Size and Growth Rate of Valsartan
-
3.4.2 Market Size and Growth Rate of Telmisartan
-
3.4.3 Market Size and Growth Rate of Losartan
-
3.4.4 Market Size and Growth Rate of Irbesartan
-
3.4.5 Market Size and Growth Rate of Azilsartan
-
3.4.6 Market Size and Growth Rate of Olmesartan
4 Segmentation of AT1 Receptor Antagonists Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of AT1 Receptor Antagonists by Major End-Users
-
4.4.1 Market Size and Growth Rate of AT1 Receptor Antagonists in Hypertension
-
4.4.2 Market Size and Growth Rate of AT1 Receptor Antagonists in Cardiovascular Diseases
-
4.4.3 Market Size and Growth Rate of AT1 Receptor Antagonists in Kidney Diseases
-
4.4.4 Market Size and Growth Rate of AT1 Receptor Antagonists in Other
5 Market Analysis by Regions
-
5.1 USA AT1 Receptor Antagonists Production Analysis by Regions
-
5.2 USA AT1 Receptor Antagonists Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA AT1 Receptor Antagonists Landscape Analysis
-
6.1 West USA AT1 Receptor Antagonists Landscape Analysis by Major Types
-
6.2 West USA AT1 Receptor Antagonists Landscape Analysis by Major End-Users
7 South USA AT1 Receptor Antagonists Landscape Analysis
-
7.1 South USA AT1 Receptor Antagonists Landscape Analysis by Major Types
-
7.2 South USA AT1 Receptor Antagonists Landscape Analysis by Major End-Users
8 Middle West USA AT1 Receptor Antagonists Landscape Analysis
-
8.1 Middle West USA AT1 Receptor Antagonists Landscape Analysis by Major Types
-
8.2 Middle West USA AT1 Receptor Antagonists Landscape Analysis by Major End-Users
9 Northeast USA AT1 Receptor Antagonists Landscape Analysis
-
9.1 Northeast USA AT1 Receptor Antagonists Landscape Analysis by Major Types
-
9.2 Northeast USA AT1 Receptor Antagonists Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sanofi SA
-
10.1.1 Sanofi SA Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Astra Zeneca
-
10.2.1 Astra Zeneca Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 GSK
-
10.3.1 GSK Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Jhonson and Johnson
-
10.4.1 Jhonson and Johnson Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Bayer
-
10.5.1 Bayer Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Novartis
-
10.6.1 Novartis Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Teva Pharmaceutical
-
10.7.1 Teva Pharmaceutical Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Eli Lilly and Company
-
10.8.1 Eli Lilly and Company Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Pfizer
-
10.9.1 Pfizer Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Bristol-Myers Squibb
-
10.10.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Merck
-
10.11.1 Merck Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Valsartan from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Telmisartan from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Losartan from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Irbesartan from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Azilsartan from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Olmesartan from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Hypertension from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Kidney Diseases from 2016 to 2027
-
Figure USA AT1 Receptor Antagonists Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA AT1 Receptor Antagonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of AT1 Receptor Antagonists Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of AT1 Receptor Antagonists
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of AT1 Receptor Antagonists by Different Types from 2016 to 2027
-
Table Consumption Share of AT1 Receptor Antagonists by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Valsartan
-
Figure Market Size and Growth Rate of Telmisartan
-
Figure Market Size and Growth Rate of Losartan
-
Figure Market Size and Growth Rate of Irbesartan
-
Figure Market Size and Growth Rate of Azilsartan
-
Figure Market Size and Growth Rate of Olmesartan
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of AT1 Receptor Antagonists by Different End-Users from 2016 to 2027
-
Table Consumption Share of AT1 Receptor Antagonists by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hypertension
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Kidney Diseases
-
Figure Market Size and Growth Rate of Other
-
Table USA AT1 Receptor Antagonists Production by Regions
-
Table USA AT1 Receptor Antagonists Production Share by Regions
-
Figure USA AT1 Receptor Antagonists Production Share by Regions in 2016
-
Figure USA AT1 Receptor Antagonists Production Share by Regions in 2021
-
Figure USA AT1 Receptor Antagonists Production Share by Regions in 2027
-
Table USA AT1 Receptor Antagonists Consumption by Regions
-
Table USA AT1 Receptor Antagonists Consumption Share by Regions
-
Figure USA AT1 Receptor Antagonists Consumption Share by Regions in 2016
-
Figure USA AT1 Receptor Antagonists Consumption Share by Regions in 2021
-
Figure USA AT1 Receptor Antagonists Consumption Share by Regions in 2027
-
Table West USA AT1 Receptor Antagonists Consumption by Types from 2016 to 2027
-
Table West USA AT1 Receptor Antagonists Consumption Share by Types from 2016 to 2027
-
Figure West USA AT1 Receptor Antagonists Consumption Share by Types in 2016
-
Figure West USA AT1 Receptor Antagonists Consumption Share by Types in 2021
-
Figure West USA AT1 Receptor Antagonists Consumption Share by Types in 2027
-
Table West USA AT1 Receptor Antagonists Consumption by End-Users from 2016 to 2027
-
Table West USA AT1 Receptor Antagonists Consumption Share by End-Users from 2016 to 2027
-
Figure West USA AT1 Receptor Antagonists Consumption Share by End-Users in 2016
-
Figure West USA AT1 Receptor Antagonists Consumption Share by End-Users in 2021
-
Figure West USA AT1 Receptor Antagonists Consumption Share by End-Users in 2027
-
Table South USA AT1 Receptor Antagonists Consumption by Types from 2016 to 2027
-
Table South USA AT1 Receptor Antagonists Consumption Share by Types from 2016 to 2027
-
Figure South USA AT1 Receptor Antagonists Consumption Share by Types in 2016
-
Figure South USA AT1 Receptor Antagonists Consumption Share by Types in 2021
-
Figure South USA AT1 Receptor Antagonists Consumption Share by Types in 2027
-
Table South USA AT1 Receptor Antagonists Consumption by End-Users from 2016 to 2027
-
Table South USA AT1 Receptor Antagonists Consumption Share by End-Users from 2016 to 2027
-
Figure South USA AT1 Receptor Antagonists Consumption Share by End-Users in 2016
-
Figure South USA AT1 Receptor Antagonists Consumption Share by End-Users in 2021
-
Figure South USA AT1 Receptor Antagonists Consumption Share by End-Users in 2027
-
Table Middle West USA AT1 Receptor Antagonists Consumption by Types from 2016 to 2027
-
Table Middle West USA AT1 Receptor Antagonists Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA AT1 Receptor Antagonists Consumption Share by Types in 2016
-
Figure Middle West USA AT1 Receptor Antagonists Consumption Share by Types in 2021
-
Figure Middle West USA AT1 Receptor Antagonists Consumption Share by Types in 2027
-
Table Middle West USA AT1 Receptor Antagonists Consumption by End-Users from 2016 to 2027
-
Table Middle West USA AT1 Receptor Antagonists Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA AT1 Receptor Antagonists Consumption Share by End-Users in 2016
-
Figure Middle West USA AT1 Receptor Antagonists Consumption Share by End-Users in 2021
-
Figure Middle West USA AT1 Receptor Antagonists Consumption Share by End-Users in 2027
-
Table Northeast USA AT1 Receptor Antagonists Consumption by Types from 2016 to 2027
-
Table Northeast USA AT1 Receptor Antagonists Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA AT1 Receptor Antagonists Consumption Share by Types in 2016
-
Figure Northeast USA AT1 Receptor Antagonists Consumption Share by Types in 2021
-
Figure Northeast USA AT1 Receptor Antagonists Consumption Share by Types in 2027
-
Table Northeast USA AT1 Receptor Antagonists Consumption by End-Users from 2016 to 2027
-
Table Northeast USA AT1 Receptor Antagonists Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA AT1 Receptor Antagonists Consumption Share by End-Users in 2016
-
Figure Northeast USA AT1 Receptor Antagonists Consumption Share by End-Users in 2021
-
Figure Northeast USA AT1 Receptor Antagonists Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA
-
Figure Sales and Growth Rate Analysis of Sanofi SA
-
Figure Revenue and Market Share Analysis of Sanofi SA
-
Table Product and Service Introduction of Sanofi SA
-
Table Company Profile and Development Status of Astra Zeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astra Zeneca
-
Figure Sales and Growth Rate Analysis of Astra Zeneca
-
Figure Revenue and Market Share Analysis of Astra Zeneca
-
Table Product and Service Introduction of Astra Zeneca
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Jhonson and Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jhonson and Johnson
-
Figure Sales and Growth Rate Analysis of Jhonson and Johnson
-
Figure Revenue and Market Share Analysis of Jhonson and Johnson
-
Table Product and Service Introduction of Jhonson and Johnson
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Teva Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
-
Table Product and Service Introduction of Teva Pharmaceutical
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
